Cargando…
Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone
Ataxia telangiectasia (A-T) is an incurable and rare hereditary syndrome. In recent times, treatment with glucocorticoid analogues has been shown to improve the neurological symptoms that characterize this condition, but the molecular mechanism of action of these analogues remains unknown. Hence, th...
Autores principales: | Menotta, Michele, Orazi, Sara, Gioacchini, Anna Maria, Spapperi, Chiara, Ricci, Anastasia, Chessa, Luciana, Magnani, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880408/ https://www.ncbi.nlm.nih.gov/pubmed/29608596 http://dx.doi.org/10.1371/journal.pone.0195388 |
Ejemplares similares
-
Ataxia-telangiectasia: A new remitting form with a peculiar transcriptome signature
por: Leuzzi, Vincenzo, et al.
Publicado: (2018) -
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T
por: Menotta, Michele, et al.
Publicado: (2017) -
New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
por: Ricci, Anastasia, et al.
Publicado: (2022) -
Dexamethasone induces p21(cip1/waf1) expression via FoxO3a independently of the Lamin A/C‐HDAC2 interaction in Ataxia Telangiectasia
por: Ricci, Anastasia, et al.
Publicado: (2023) -
Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
por: Leuzzi, Vincenzo, et al.
Publicado: (2015)